Study population:
Consecutive patients 18 years of age and older who were diagnosed with
MI using the Third Universal Definition of Myocardial Infarction and who
underwent a diagnostic coronary angiography were included in the study
population. Each participating physician arranged the management of
treatment on their own, and the study patients were not given any
medical procedure other than guideline directed therapy. Potential study
patients were informed about the study and asked to sign informed
consent forms after coronary angiography (or percutaneous coronary
interventions if needed). Patients with stable coronary artery disease,
unstable angina pectoris, coronary revascularization history (PCI or
CABG), or type 4 or type 5 MI and patients under the years of 18 and who
did not sign the informed consent were excluded from the study.